COVID-19: The Impact on Litigation in the Pharmaceutical Industry and Mitigating Risk with Litigation Finance
This program features a discussion on how COVID-19 has impacted the of pharmaceutical and medical product supply chains. Presenters discuss technology trends on pharmaceutical operations, nature of potential disputes, force majeure, and other key topics.
- Pharma industry disputes and impact of operations
- Litigation effect on federal operations -- future disputes likely to result from related business disruption
- Impact on federal court and other agencies, including FDA and USPTO
- Applying litigation finance to pharma and life sciences